BCIM
SLXP

British Columbia Investment Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

British Columbia Investment Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,290
Closed -$569K – 736
2015
Q1 		$569K Hold
3,290
– – 0.01% 679
2014
Q4 		$378K Buy
+3,290
New +$399K ﹤0.01% 723

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

British Columbia Investment Management's SLXP Position: Q2 2015 in Review

British Columbia Investment Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 3,290 shares — an estimated $569K sold.

British Columbia Investment Management first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $569K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • British Columbia Investment Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • British Columbia Investment Management sold 3,290 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $569K.
  • British Columbia Investment Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • British Columbia Investment Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $569K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on British Columbia Investment Management's 13F filing for Q2 2015, filed 27 Jul 2015.